Edward F. Fritsch
Edward F. Fritsch (born June 1, 1950) is a scientist in the field of molecular biology and cancer immunology.

As a postdoctoral fellow under Tom Maniatis at California Institute of Technology, Fritsch entered the field of recombinant DNA by constructing the first complete library of the human genome along with Dr. Richard Lawn. In 1982, Fritsch, Joe Sambrook and Tom Maniatis, wrote "Molecular Cloning: A Laboratory Manual", which was considered "omnipresent in Molecular Biology laboratories and [...] utilized to the point where it is frequently referred to as ‘The Bible’.” Fritsch helped initiate and for four years co-taught the widely successful Cold Spring Harbor course on Molecular Cloning. Fritsch’s work in molecular cloning continued at Genetics Institute, acquired by Wyeth in 1992, where he worked on the discovery and production of therapeutic recombinant proteins, including the cloning of the erythropoietin (EPO) gene

Fritsch then joined Phylos, Inc. to utilize a in vitro, directed-evolution technology to discover new protein therapeutics, eventually becoming Chief Scientific Officer

He later worked with Cathy Wu and Nir Hacohen at the Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard. There he led the development of NeoVax, a first-in-class personalized neoantigen cancer vaccine through IND approval and successful execution of two clinical trials

In 2015, he co-founded Neon Therapeutics, Inc., (acquired by BioNTech in 2020 for $67M), as Chief Technology Officer to work on personalizedcancer vaccines. In 2019, he left Neon to re-join the Dana-Farber Cancer Institute and the Broad Institute to continue work on the subject.
Q7202
molecular biology
Concept
Q4891747
cancer immunology
UNK
Q554898
Tom Maniatis
PER
Q161562
California Institute of Technology
LOC
Q953080
Cold Spring Harbor
LOC
Q5532944
Genetics Institute
ORG
Q901932
Wyeth
ORG
Q218706
erythropoietin
Concept
Q1159198
Dana-Farber Cancer Institute
LOC
Q4971893
Broad Institute
LOC
Q49108
MIT
ORG
Q13371
Harvard
ORG
Q2378309
cancer vaccine
Concept
Q103221033
Edward F. Fritsch
PER
1950-06-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
June 1, 1950
DATE
1982-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
1982
DATE
1992-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
1992
DATE
2015-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2015
DATE
2020-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2020
DATE
2019-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2019
DATE
+67^^http://www.w3.org/2001/XMLSchema#decimal
67
NUMBER
employer